Co-Authors
This is a "connection" page, showing publications co-authored by Ahmed Kandeil and Mahmoud Shehata.
Connection Strength
1.155
-
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines (Basel). 2021 Mar 03; 9(3).
Score: 0.233
-
Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2. PLoS One. 2020; 15(10):e0241471.
Score: 0.228
-
Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt. Microbiol Resour Announc. 2020 May 28; 9(22).
Score: 0.221
-
Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerg Microbes Infect. 2019; 8(1):103-108.
Score: 0.201
-
Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. PLoS Pathog. 2021 03; 17(3):e1009413.
Score: 0.058
-
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel). 2020 Dec 04; 13(12).
Score: 0.057
-
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors. Front Microbiol. 2020; 11:596851.
Score: 0.057
-
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science. Microorganisms. 2020 Jul 02; 8(7).
Score: 0.056
-
Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016. Euro Surveill. 2017 Mar 16; 22(11).
Score: 0.044